Filing date Form Description Filing Group View
20-F Registration of securities of foreign private issuers pursuant to section 12(b) or (g)
Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
20-F Registration of securities of foreign private issuers pursuant to section 12(b) or (g)
Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
NT 20-F NT 20-F    
Annual Filings
View HTML
NT 20-F NT 20-F    
Annual Filings
View HTML
20-F Registration of securities of foreign private issuers pursuant to section 12(b) or (g)
Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
NT 20-F NT 20-F    
Annual Filings
View HTML
20-F/A Amendment to a previously filed 20-F
Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
20-F Registration of securities of foreign private issuers pursuant to section 12(b) or (g)
Annual Filings
View HTML
20-F Registration of securities of foreign private issuers pursuant to section 12(b) or (g)
Annual Filings
View HTML
10-K/A Amendment to a previously filed 10-K
Annual Filings
View HTML EX-101.INS - XBRL INSTANCE FILE

Data provided by Kaleidoscope.


Investor Contact Information

Company

Sofgen Pharma
9 Rue De Bitbourg
L-1273 Luxembourg
Grand Duchy of Luxembourg

Investor Relations

Sofgen Pharma Company Contact
ir@SofgenPharma.com

Search Investor Relations